Assessing the mortality rate for patients with liver cancer not vaccinated against COVID-19
The mortality rate during the first month of infection for patients with advanced-stage hepatocellular carcinoma rose to 20.7%.
News about Liver cancer
How have treatments for hepatocellular carcinoma improved?
Researchers at the Hospital Clínic-IDIBAPS and the University of Barcelona have published a review article in the journal Nature Cancer in which they1
Controlling the dose of a liver transplant rejection drug reduces the risk of developing cancer
A multi-centre study, in which the Clínic-IDIBAPS participated, identified, in nearly 2,500 transplant patients, the main risk factors for the develo1
The role of immunotherapy in hepatocellular carcinoma
Immunotherapy has revolutionized the treatment of hepatocellular carcinoma. Researchers from the Hospital Clínic-IDIBAPS have published a review in t1
IDIBAPS researchers discover a protein that favours diet-induced obesity
The inhibition of this molecule, in addition to reducing the predisposition towards developing the disease, also reduces the alteration of the microb1
Dra. Maria Reig: “Over the last 15 years, there has been a revolution in the treatment of liver cance
Interview with Dr Maria Reig, head of the Hepatic Oncology Unit
A meta-analysis of phase-III trials shows that immunotherapy is more efficacious in liver cancer of viral origin than of nonviral origin
Researchers at IDIBAPS have led a study, published in the journal Gastroenterology, in which they analyzed the clinical trials published in the past1
Molecular map of hepatocellular carcinoma caused by fatty liver disease revealed
IDIBAPS researchers have drafted a molecular map of the most common type of liver cancer, hepatocellular carcinoma, when the origin is fatty liver di1
A study in Nature concludes that immunotherapy is less efficacious in nonviral liver cancer
An article published in the journal Nature suggests that immunotherapy is effective in patients with HCC of viral origin but does not increase surviv1
Two articles review current knowledge on the management of hepatocellular carcinoma
Clínic-IDIBAPS researchers have coordinated two review articles on hepatocellular carcinoma (HCC), the most common type of liver cancer, in which the1